NMDA receptor-dependent regulation of miRNA expression and association with Argonaute during LTP in vivo by Pai, Balagopal et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NMDA receptor-dependent regulation of miRNA expression and
association with Argonaute during LTP in vivo
Citation for published version:
Pai, B, Siripornmongcolchai, T, Berentsen, B, Pakzad, A, Vieuille, C, Pallesen, S, Pajak, M, Simpson, TI,
Armstrong, JD, Wibrand, K & Bramham, CR 2014, 'NMDA receptor-dependent regulation of miRNA
expression and association with Argonaute during LTP in vivo' Frontiers in Cellular Neuroscience, vol. 7, pp.
285. DOI: 10.3389/fncel.2013.00285
Digital Object Identifier (DOI):
10.3389/fncel.2013.00285
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Frontiers in Cellular Neuroscience
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
ORIGINAL RESEARCH ARTICLE
published: 13 January 2014
doi: 10.3389/fncel.2013.00285
NMDA receptor-dependent regulation of miRNA expression
and association with Argonaute during LTP in vivo
Balagopal Pai1†, Taweeporn Siripornmongcolchai1†, Birgitte Berentsen1, Ashraf Pakzad1,
Christel Vieuille1, Ståle Pallesen2, Maciej Pajak3, T. Ian Simpson3,4, J. Douglas Armstrong3,
Karin Wibrand1 and Clive R. Bramham1*
1 Department of Biomedicine and K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Bergen, Norway
2 Department of Psychosocial Science, University of Bergen, Bergen, Norway
3 Institute for Adaptive and Neural Computation, School of Informatics, University of Edinburgh, Edinburgh, UK
4 Biomathematics and Statistics Scotland, JCMB, Edinburgh, UK
Edited by:
Tommaso Pizzorusso, Università
degli Studi di Firenze, Italy
Reviewed by:
Angel Barco, Instituto de
Neurociencias de Alicante, Spain
Riccardo Brambilla, San Raffaele
Scientific Institute and University,
Italy
*Correspondence:
Clive R. Bramham, Department of
Biomedicine and K.G. Jebsen
Centre for Research on
Neuropsychiatric Disorders,
University of Bergen, Jonas Lies
vei 91, N-5009 Bergen, Norway
e-mail: clive.bramham@
biomed.uib.no
†Shared first authorship.
microRNAs (miRNAs) are major regulators of protein synthesis in the brain. A major
goal is to identify changes in miRNA expression underlying protein synthesis-dependent
forms of synaptic plasticity such as long-term potentiation (LTP). Previous analyses
focused on changes in miRNA levels in total lysate samples. Here, we asked
whether changes in total miRNA accurately reflect changes in the amount of miRNA
bound to Argonaute protein within the miRNA-induced silencing complex (miRISC).
Ago2 immunoprecipitation was used to isolate RISC-associated miRNAs following
high-frequency stimulation (HFS)-induced LTP in the dentate gyrus of anesthetized
rats. Using locked-nucleic acid-based PCR cards for high-throughput screening and
independent validation by quantitative TaqMan RT-PCR, we identified differential regulation
of Ago2-associated and total miRNA expression. The ratio of Ago2/total miRNA
expression was regulated bidirectionally in a miRNA-specific manner and was largely
dependent on N-methyl-D-aspartate receptor (NMDA) activation during LTP induction.
The present results identify miRNA association with Ago2 as a potential control point
in activity-dependent synaptic plasticity in the adult brain. Finally, novel computational
analysis for targets of the Ago2-associated miRNAs identifies 21 pathways that are
enriched and differentially targeted by the miRNAs including axon guidance, mTOR, MAPK,
Ras, and LTP.
Keywords: synaptic plasticity, microRNA, RNA-induced silencing complex, Argonaute, microRNA target prediction,
gene expression, protein synthesis, hippocampus
INTRODUCTION
Stable forms of activity-dependent synaptic plasticity require
coordinated gene transcription and bursts of protein synthe-
sis and degradation. Rapid regulation of local protein synthesis
in dendrites is considered important for synaptic homeostasis
and plasticity (Bramham and Wells, 2007; Martin and Ephrussi,
2009). In recent years miRNAs have emerged as key modula-
tors of neuronal protein synthesis. miRNAs are short non-coding
RNAs (∼22 nucleotides) that bind to partially complementary
sites on the 3′ UTR of target mRNAs where they act to inhibit
protein synthesis (Filipowicz et al., 2008; Djuranovic et al., 2011;
Huntzinger and Izaurralde, 2011). Many new brain-specific miR-
NAs have appeared with vertebrate and primate evolution and
roles for specific miRNAs in neurogenesis, dendritic spine mor-
phogenesis, synaptic regulation, plasticity, and memory storage
have been demonstrated (Vo et al., 2005; Krichevsky et al., 2006;
Rajasethupathy et al., 2009; Siegel et al., 2009; Mellios et al., 2011;
Tognini et al., 2011). The target diversity, specificity, and activity-
dependent regulation make miRNAs attractive as modulators of
local protein synthesis and synaptic plasticity.
In the canonical biogenesis pathway, miRNAs are transcribed
as long primary transcripts and processed in the nucleus by the
RNase III enzyme Drosha to generate a stem-loop structured
precursor. The precursor miRNA is then exported to the cyto-
plasm where a second RNase III enzyme, Dicer, generates a
mature double-stranded miRNA intermediate. One of these
strands, the guide strand, is recognized and bound by the pro-
tein Argonaute (Ago), which further functions in recruitment of
the multi-protein, miRNA-induced silencing complex (miRISC)
(Bartel, 2004). The passenger strand of the miRNA duplex is nor-
mally destroyed. Once assembled on target bound miRNA, the
miRISC inhibits protein synthesis by repressing translation, pro-
moting mRNA decay, or some combination of the two processes
(Filipowicz et al., 2008; Huntzinger and Izaurralde, 2011; Béthune
et al., 2012; Djuranovic et al., 2012).
MicroRNA activity is modulated through changes in miRNA
biogenesis, miRNA turnover, and regulation of RISC effector pro-
teins (Lugli et al., 2005; Ashraf et al., 2006; Kosik, 2006; Banerjee
et al., 2009; Krol et al., 2010a,b; Wibrand et al., 2010) A previous
study on miRNA expression in dentate gyrus long-term potentia-
tion (LTP) provided evidence for rapid, activity-dependent decay
of several mature miRNAs in addition to upregulation of miRNA
by transcription (Wibrand et al., 2010). In that study and pre-
vious work on chemically induced LTP (Park and Tang, 2009),
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miRNA levels were measured in whole tissue lysate. The gen-
eral assumption has been that guide-stranded mature miRNA is
predominantly, if not exclusively, bound to Argonaute. However,
mounting evidence suggest that miRNA binding to Argonaute is
both reversible and regulated (Meister, 2013).
Using Ago2 immunoprecipitation, we demonstrate rapid, dif-
ferential regulation of Ago2-associated and total miRNAs fol-
lowing LTP induction in the dentate gyrus in vivo. The ratio
of Ago2/total miRNA expression was regulated bidirectionally
in a miRNA-specific manner and was coupled to N-methyl-D-
aspartate (NMDA) receptor-dependent LTP induction. Hence,
these findings identify regulation of miRNA:Ago2 interactions as
a potential control point in long-term synaptic plasticity of the
adult dentate gyrus.
Finally we use an integrated miRNA target prediction
approach to inform pathway enrichment analyses in which we
find thatmany of themajor pathways traditionally associated with
the regulation of synaptic plasticity are targeted, including the
mTOR, MAPK, and Ras pathways. Surprisingly, the axon guid-
ance pathway is the most highly enriched, but includes many
genes already known to play a role in synaptic plasticity.
MATERIALS AND METHODS
In vivo ELECTROPHYSIOLOGY
Experiments were carried out under ethical standards approved
by the Norwegian Committee for Experiments on Animals.
In vivo electrophysiological experiments were carried out on
30 adult male rats of the Sprague–Dawley outbred strain,
weighing 250–350 g. The electrophysiological procedures have
been detailed elsewhere (Messaoudi et al., 2002; Panja et al.,
2009). Rats were anesthetized with urethane and electrodes
were stereotactically placed for selective stimulation of the
medial perforant pathway and recording of evoked field poten-
tials in the hilar region of the dentate gyrus. A concentric
bipolar stimulating electrode (input impedance ∼40 M; tip
separation 500μm; SNEX 100; Rhodes Medical Instruments,
Woodland Hills, CA) was lowered into the dorsomedial aspect
of the angular bundle for stimulation of the medial perforant
path.
The recording electrode was slowly lowered into the dor-
sal hippocampus until a positive-going field EPSP (fEPSP)
of maximum slope was obtained in the dentate hilus
(7.9mm posterior to bregma and 4.2mm lateral from mid-
line for stimulation; 3.9mm posterior and 2.3mm lateral
for recording). Biphasic rectangular test pulses of 150μs
duration were applied every 30 s throughout the experi-
ment (0.033Hz) except during the period of high-frequency
stimulation (HFS). Responses were allowed to stabilize, and
20min of baseline recording was obtained. HFS consisted
of 400-Hz, 8-pulse stimulus trains repeated 4 times with
10 s between each train. HFS was applied three times with
5min between each session. The total number of pulses was
128. After HFS, evoked responses were collected for peri-
ods of 30 and 120min. Signals from the dentate hilus were
amplified, filtered (1Hz and 10Hz), and digitized (25Hz).
Acquisition and analysis of field potentials were accom-
plished using Data Wave Technologies Work Bench Software
(Longmont, CO). The maximum slope of the fEPSP was
measured and the averages of four consecutive responses were
obtained.
INTRAHIPPOCAMPAL INFUSION
The recording electrode with an attached guide cannula was
lowered into the dentate gyrus as described for the record-
ing electrode above. An inner infusion cannula (31 gauge) was
then inserted so it protruded 300μm below the end of the
guide. The tip of the infusion cannula was located in the deep
stratum lacunosum-moleculare of field CA1, 700μm above the
hilar recording site and 300–400μm above the medial perforant
synapse (Messaoudi et al., 2007). The inner infusion cannula was
connected via a polyethylene (PE50) tube to a 3μl Hamilton
syringe (Reno, NV) and infusion pump. 0.3μl of 2-Amino-5-
phosphonopentanoic acid (AP5, 50mM prepared in 1× PBS;
Tocris) was infused over 12min at a rate of 0.085μl/min, and
test pulse stimulation was continued for a further 18min prior
to HFS.
DENTATE GYRUS DISSECTION AND SAMPLE PREPARATION
At the end of the electrophysiological recordings rats were decap-
itated, the brain was extracted and rinsed with ice-cold saline
and both hippocampi were removed within less than 3min. The
dentate gyri were then rapidly dissected on ice and immediately
frozen on dry ice.
ARGONAUTE 2 IMMUNOPRECIPITATION
Immunoprecipitation was performed according to Choe et al.
(2010) with minor modifications. Forty microliters of protein
G-sepharose (17061801, GE Health Care Bioscience AB) was
incubated with 3μg of mouse monoclonal Ago2 antibody (anti-
EIF2C2) (H00027161-M01, Abnova) at room temperature in
a rotary shaker (25 rpm) for 1.5 h. Immunoprecipitation using
purified mouse IgG (558509, BD Pharmingen) served as a con-
trol for detection of non-specific protein binding. The sepharose
beads were blocked with 2% yeast tRNA (R4018, Sigma-Aldrich)
and 1% BSA (9048-46-8, Sigma-Aldrich) in 1× PBS at room
temperature in a rotary shaker (25 rpm) for 30min. Dentate
gyri were homogenized (Dounce homogenizer) in ice cold lysis
buffer containing 25mM Tris (Ambion Life Sciences, Carlsbad,
CA, USA), 150mM NaCl, 2mM MgCl2, 0.5% NP-40 (Ambion
Life Sciences, Carlsbad, CA, USA), 0.5mM DTT (Ambion Life
Sciences, Carlsbad, CA, USA), 0.4 unit RNAse inhibitor (Ambion
Life Sciences, Carlsbad, CA, USA), and protease inhibitor cock-
tail (Roche Diagnostics GmbH) 1 tablet/10ml. The homogenate
was centrifuged at 4◦C (10,000 rpm, 15min) and subjected to
pre-clearing with 40μl protein-G sepharose at 4◦C for 30min,
and centrifuged at 3000 rpm for 3min. The protein concentra-
tion of the pre-cleared supernatant was determined by the BCA
Protein Assay (BCA Protein Assay kit 23227, Thermo Scientific).
A small aliquot of the supernatant was separately stored at 4◦C for
analysis of total lysate (input). The antibody bound beads were
incubated with 750μg of pre-cleared protein at 4◦C in a rotary
shaker (25 rpm) for 2.5 h. Non-specifically bound proteins were
removed from the sepharose beads by giving four washes: first
wash using lysis buffer, second wash with lysis buffer containing
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900mM NaCl instead of 150mM, a third wash in the standard
lysis buffer, and a final wash in lysis buffer containing 0.05%
NP-40.
RNA ISOLATION
The Ago2 immunoprecipitate (referred to as Ago2 IP or Ago2
pellet) and the input samples were treated with 250μl DNAse
solution containing 25μl of 10× DNAse1 buffer, 1 unit DNAse1
(Ambion Life Sciences, Carlsbad, CA, USA) and 50 unit RNAse
inhibitor (Ambion Life Sciences, Carlsbad, CA, USA) at 37◦C for
20min for genomic DNA removal. Both the input (containing
total RNA including all miRNAs) and the Ago2 IP (containing
all RNAs in Ago2 complex including Ago2-associated miRNAs)
were then treated with 500μl of Trizol (Ambion Life Sciences,
Carlsbad, CA, USA) for 5min and 200μl of Chloroform (Sigma-
Aldrich, St. Louis, MO, USA), and subjected to centrifugation at
4◦C, 14,000 rpm for 15min. The water phase containing RNAwas
collected. RNA was precipitated in a solution containing 500μl
isopropanol, 5μg glycogen (Ambion Life Sciences, Carlsbad, CA,
USA), and 10% v/v ammonium acetate (Ambion Life Sciences,
Carlsbad, CA, USA) at –20◦C for at least 16 h. The preparation
was then centrifuged at 4◦C, 14,000 rpm for 45–60min. The pel-
let was washed once in 100% ethanol, and once in 80% ethanol
prior to centrifugation at 4◦C, 14,000 rpm for 20min. The RNA
pellet was air-dried for 15min, and dissolved in 25μl of nuclease-
free water. The quantity and quality of the RNA were deter-
mined by absorbance measurement at 260/280 nm. The quality
of the total RNA was assessed by PCR-Quality Control (PCR-QC)
using TaqMan® Gene expression assays (Applied Biosystems, Life
Sciences, Carlsbad, CA, USA) for amplification of miRNAs which
are known to express in the brain: miR-347 (assay 1334) andmiR-
151 (assay 1330). Argonaute immunoprecipitation was validated
by western blot analysis of Ago2 protein in cortex, cornu ammo-
nis, dentate gyrus, and HEK293 cells transfected with GFP-Ago2
vector.
HIGH-THROUGHPUT PCR CARD ANALYSIS OF microRNA EXPRESSION
High-throughput PCR analysis was performed using the miR-
CURY LNA universal RT miRNA Ready-to-Use PCR Mouse and
Rat panel 1, V2.R (PCR card 203706, Exiqon). Twenty nanograms
total RNA was reverse-transcribed to cDNA according to the uni-
versal cDNA synthesis kit instructions (203300, Exiqon). The
qPCR was performed according to the SYBR Green Master Mix
Universal RT kit instructions (203400, Exiqon). The PCR reac-
tion was performed on a Roche Light Cycler® 480 II (Roche
Applied Science). Briefly, a poly-A tail is added to the mature
miRNA template. The cDNA template is then amplified using
miR-specific LNA™ enhanced forward and reverse primers that
are pre-aliquoted in the PCR card. The reverse primers detect the
poly-T tail and the 3′ part of the mature microRNA sequence,
ensuring specific amplification of the mature microRNA.
Of 384 wells in the PCR card, 373 wells contain different
primer sets for 373 miRNAs of known sequences present in mir-
Base version 16. In addition, 11 wells are used for the following
controls: an empty well (blank), three interplate-calibrators, a
primer pair specific to synthetic oligo-RNA template in the cDNA
synthesis master mix (for quality control of cDNA synthesis), and
wells for the six reference genes miR-423-3p, miR-103, miR-191,
u6 (small nucleolar RNA), RNU-5G (small nucleolar RNA), and
rnu-1A1 (small nucleolar RNA).
The data analysis was performed according to the manu-
facturer’s instructions (Exiqon GenEx qPCR analysis software).
For each of three rats, the Ct (threshold cycle) values from the
input and Ago2 IP samples collected at 30 and 120min post-
HFS were normalized using global normalization, an appropriate
approach for large scale analysis (>100 assays) in which most
miRNAs are not regulated. The Ct value of each miRNA was
normalized to the mean Ct of all the miRNAs represented on
the PCR card. Differences in miRNA expression between the
treated and contralateral control dentate gyrus were compared
by a Student’s t-test with Dunn–Bonferroni correction (GeneEx
software). One-Way ANOVA and post hoc Fisher’s LSD was addi-
tionally applied to the data analysis in order to allow detection of
possible false-negative results from Dunn–Bonferroni correction.
TaqMan REAL-TIME RT-PCR ANALYSIS OF microRNA
Ten nanograms total RNA was reverse-transcribed to cDNA
according to the TaqMan® miRNA reverse transcription Kit
instructions (4366597, Applied Biosystems) provided along with
the TaqMan® RT primer specific to miRNA of interest. TaqMan®
RT primers (Applied Biosystems) RT00-2602 (miR-384-5p),
RT00-0413 (miR-29b), RT00-0522 (miR-219), RT00-2017 (miR-
592), RT00-0580 (miR-20a), RT00-0382 (let-7f), RT00-2230
(miR-330-5p), RT00-0548 (miR-338), RT00-0526 (miR-223),
RT00-2551 (miR-212), RT00-0480 (miR-181a), RT000426 (miR-
34a), RT000395 (miR-19a), RT001061 (miR-326), and RT00-
0492 (miR-193a) were used.
To identify the most stable gene for normalization, multi-
factor ANOVA for multiple comparisons was used to analyze
the Ct (threshold cycle) values of 373 miRNAs in Ago IP at 30
and 120min and in input at 30 and 120min (from the PCR
cards). Two genes (miR-345-3p and miR-214) with most sta-
ble expression across samples (with highest P-value and lowest
SD in Multi-Factor ANOVA analysis) were tested by qPCR in
Ago2 IP (n = 6) and input samples (n = 6) in both treated and
control dentate gyrus obtained at 30min post-HFS. Rno-miR-
345-3p was found to be the most stably expressed with the
lowest range of Ct values among all samples, and therefore was
used as an optimal normalizer in qPCR validation of miRNA
expression.
cDNA pre-amplification was performed to allow accurate and
reliable qPCR analyses of low abundance miRNAs. Fourteen
cycles of exponential phase cDNA pre-amplification was per-
formed according to the TaqMan® PreAmp Master Mix instruc-
tions (4391128, Applied Biosystems). The pre-amplified cDNA
was diluted 10 times and subjected to qPCR. The qPCR was per-
formed on a Roche Light Cycler®480 II (Roche Applied Science)
using diluted pre-amplified cDNA from the individual dentate
gyrus input and Ago2 IP samples. After reverse transcription
and pre-amplification, qPCR was analyzed in a 25μl reaction
volume using 2× TaqMan® Universal PCR Master Mix II with
no uracil-N-glycosylase (Applied Biosystems). PCR quantifica-
tion was performed in triplicate using the relative standard
curve method to determine gene expression levels. TaqMan®Gene
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expression assays (Applied Biosystems) were used corresponding
to the TaqMan® RT primers used in cDNA synthesis.
QUANTITATIVE PCR ANALYSIS OF Arc mRNA
For analysis of Arc mRNA, 2μg total RNA was reverse-
transcribed to cDNA according to the MMLV reverse transcrip-
tase kit instructions (2043, Ambion). qPCR was performed on
a Roche Light Cycler® 480 II (Roche Applied Science) using
cDNA corresponding to 10 ng total RNA of individual homog-
enized dentate gyrus. The qPCR was analyzed in 25μl reaction
using 2×TaqMan® PCR mix (Applied Biosystems). The qPCR
quantification was performed in triplicate using relative standard
curve method to determine gene expression levels. Ubiquitin-B
was used as a housekeeping gene to normalize and determine
the expression level for Arc. TaqMan®Gene expression assays
(Applied Biosystems): Rn00571208_g1 (Arc) and Rn03062801_g1
(ubiquitin-B) were used.
STATISTICAL ANALYSIS FOR qPCR VALIDATION
Statistical analyses were performed using SPSS (version 16). Two
miRNAs (miR-181a and miR-193a) were undetectable in the con-
trol dentate gyrus because their Ct values were greater than 40,
and were therefore excluded from the analyses. One-Way ANOVA
was used to analyze relative expression differences between the
treated and contralateral control dentate gyrus in both Ago2 IP
and input for all miRNAs. The expression levels between differ-
ent miRNAs, as well as the differences between treatment groups
were analyzed using a One-Way ANOVA and Fisher’s LSD post
hoc test. Fold changes in treated dentate gyrus relative to the con-
tralateral control dentate gyrus were calculated for Ago2 IP and
input samples from the individual rats and averaged.
microRNA TARGET PREDICTION
To identify the putative target genes of each miRNA we first
queried four of the most widely used target prediction sources;
DIANA (Maragkakis et al., 2011), miRanda (Griffiths-Jones et al.,
2008), TargetScan (Friedman et al., 2009), and PicTar (Lall et al.,
2006). Both DIANA and PicTar report miRNA targets in Mus
musculus which we projected into Rattus norvegicus using only
direct orthologs extracted from the Ensembl Compara database
(Vilella et al., 2009).
We next quantified the agreement between predicted target
lists using Rank Product (RP) analysis (Breitling et al., 2004;
Eisinga et al., 2013). Briefly, each gene was ordered by quality
score and the geometric mean of the gene rank calculated across
prediction sources. Missing ranks were imputed for target genes
missing only one rank value, genes missing more source values
were discarded. To assess the robustness of the computed ranks we
performed a bootstrap analysis with 1000 permutations of rank
order using the Bioconductor RankProd package (Hong et al.,
2006). In order to minimize the elimination of true positive tar-
gets, genes with RP (p > 0.5) were used in subsequent pathway
analysis.
PATHWAY ANALYSIS
Integrated miRNA target gene lists from the RP step were used
as input to pathway enrichment analyses by hypergeometric test-
ing using the Bioconductor KEGGprofile package (Zhao, 2012).
Gene to KEGG pathway mappings were retrieved for every path-
way in the KEGG database (Kanehisa et al., 2011) and used to
identify pathways that were enriched in predicted miRNA target
genes (p ≤ 0.05).
RESULTS
VALIDATION OF ARGONAUTE-2 IMMUNOPRECIPITATION
Dentate gyrus lysates were immunoprecipitated with an Ago2-
specific antibody or control, non-immune IgG, and expres-
sion of the brain-specific miRNAs, miR-151, and miR-347, was
examined by qPCR. miR-151 and miR-347 levels were enriched
more than 100-fold in the Ago2 IP (Figure 1A). Furthermore,
western blot analysis detected Ago2 protein at 97 kDa in the
Ago2 pellet from naïve rat dentate gyrus, but not in the non-
immune IgG pellet (Figure 1B). As a positive control, ectopically
expressed Ago2-GFP was detected in HEK293 cells (Figure 1B).
The results confirm immunoprecipitation of Ago2 and Ago2-
associated miRNAs.
HIGH-THROUGHPUT miRNA EXPRESSION PROFILING
Brief bursts of HFS applied to the medial perforant path of anes-
thetized rats induced stable LTP of the fEPSP slope (Figure 2A).
FIGURE 1 | Validation of Argonaute 2 immunoprecipitation. (A) Specific
Ago2-immunoprecipitation of brain-enriched miRNAs. TaqMan qPCR for
brain-enriched miR-347 and miR-151 was performed in Ago2
immunoprecipitated (IP) or non-immune mouse IgG immunoprecipitated
samples from dentate gyrus. Values are means (+s.e.m.; n = 3) expressed
as fold enrichment in the Ago2 IP relative to IgG IP. (B) Ago2 immunoblots
following immunoprecipitation of dentate gyrus (DG) samples with Ago2
antibody or non-immune mouse IgG. A band at ∼97 kDa corresponding to
Ago2 was detected in Ago2, but not IgG, IP. As a positive control, HEK293
cells were transfected with GFP-Ago2. Endogenous Ago2 protein (lower
band) and GFP-Ago2 fusion protein (arrow; band at ∼127 kDa) were
detected in transfected cells.
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FIGURE 2 | Modulation of miRNA expression in total lysates and
Ago2 immunoprecipitates following LTP induction. (A) Time course
plot showing changes in the medial perforant path-evoked fEPSP slope
expressed as a percentage of baseline. Values are mean ± s.e.m.
(n = 3). Dentate gyrus tissue was obtained at 30 or 120min post-HFS.
(B–E) miRNA PCR cards from Exiqon were used to screen 373 miRNAs
in total lysates (input) and Ago2 immunoprecipitates following
high-frequency stimulation (HFS). Data for input and Ago2 IP samples for
each time point were normalized to the respective global mean of all
miRNAs expressed on the card. Values are mean (+s.e.m.) changes in
HFS-treated dentate gyrus relative to the contralateral control (n = 3).
Values are significantly different from control (Student’s t-test with
Dunn–Bonferroni correction, p < 0.05). (B) Fold change in miRNA
expression in dentate gyrus input at 30min post-HFS. (C) Fold change in
miRNA expression in dentate gyrus input at 120min post-HFS. (D) Fold
change in miRNA expression in dentate gyrus Ago2 immunoprecipitate at
30min post-HFS. (E) Fold change in miRNA expression in dentate gyrus
Ago2 immunoprecipitates at 120min post-HFS.
The dentate gyrus was rapidly micro-dissected at 30 or 120min
post-HFS. miRNA expression in the HFS-treated dentate gyrus
was compared with the contralateral, unstimulated dentate gyrus
which served as an internal control. High-throughput expression
profiling of Ago2 IP and input samples was performed using pre-
aliquoted, locked-nucleic acid based miRNA PCR primer sets in
384-well PCR plates. As there is no known reference gene stably
expressed in both the Ago2 pellet and input, a global normaliza-
tion was performed in which the Ct value of each miRNA was
normalized to the mean Ct of all the miRNAs represented on the
PCR card. Statistical differences in miRNA expression between
the treated and control dentate gyrus were assessed by a Student’s
t-test with Dunn–Bonferroni correction.
In dentate gyrus lysates (inputs), at 30min post-HFS, only 4
of 376 miRNAs represented on the panel exhibited significantly
altered expression. Fold-changes ranged between a decrease of
0.49-fold (miR-504) and an increase of 1.55-fold (miR-142)
relative to the contralateral control dentate gyrus (Figure 2B).
At 120min post-HFS, 17 miRNAs were significantly regulated,
ranging between a maximum decrease of 0.65 fold (miR-329)
and maximum increase of 1.79 fold (miR-434) (Figure 2C). In
agreement with previous results (Wibrand et al., 2012), miR-
132 was significantly upregulated at 120min post-HFS in den-
tate gyrus lysates (Figure 2C). The high-throughput analysis of
input samples indicate predominantly delayed (2 h), bidirectional
changes in miRNA expression following HFS.
In Ago2 IP samples, 14 miRNAs were upregulated at 30min
post-HFS, and only miR-29b was downregulated (Figure 2D). At
120min, 10 miRNAs were regulated (Figure 2E). None of the
miRNAs exhibiting altered expression in the Ago2 pellet at 30
or 120min post-HFS were also regulated in the input samples.
Thus, the PCR card analysis revealed rapid, differential regulation
of miRNAs in the Ago2-immunoprecipitated fraction relative to
total miRNA.
LTP-SPECIFIC, DIFFERENTIAL REGULATION OF Ago2-ASSOCIATED AND
TOTAL miRNA EXPRESSION: qPCR VALIDATION
TaqMan-based qPCR analysis of independent samples was used to
validate changes in Ago2-immunoprecipitated miRNAs at 30min
post-HFS. In the qPCR validation, four experimental groups were
used in order to identify miRNA regulation specific to LTP induc-
tion. The treatment groups were: (1) HFS + LFT; n = 6, (2)
block of LTP induction by local intrahippocampal infusion of the
NMDAR antagonist, AP5 (AP5 + HFS + LFT; n = 4). (3) LFT
alone; n = 5, and (4) AP5 + LFT; n = 5. As shown in Figure 3A,
LTP was blocked when HFS was applied in the presence of AP5.
No changes in field potentials occurred in the LFT and AP5 +
LFT treatment groups.
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FIGURE 3 | Differential expression of Ago2-associated and total miRNAs
linked to NMDA receptor-dependent LTP induction. (A) Time course plot
showing changes in the medial perforant path-evoked fEPSP slope expressed
as a percentage of baseline. Values are mean (±s.e.m.). HFS + LFT, n = 6;
AP5 + HFS + LFT, n = 4; LFT, n = 3. Dentate gyrus tissue was obtained at
30min. (B) Quantitative PCR was used to validate the expression of Arc
mRNA. Changes in Arc mRNA levels in the treated and contralateral control
dentate gyrus lysate samples were analyzed. The PCR data was normalized
to the expression of Ubiquitin-B using the Ct method. Values are mean
(+s.e.m.). HFS + LFT, n = 6; AP5 + HFS + LFT, n = 4; LFT, n = 3: AP5 + LFT,
n = 5. (C–E) Quantitative TaqMan PCR was used for independent analysis of
10 selected miRNAs from the PCR card screen. The same set of miRNAs
were analyzed in the input sample (C) and Ago2-immunoprecipitate (D).
qPCR data was normalized to expression of miR-345-3p. (C) Fold change in
miRNA expression in dentate gyrus input samples at 30min. Bar graph
shows mean fold change (+s.e.m.) in treated dentate gyrus relative to
control, contralateral dentate gyrus. Significant differences between the HFS
group and other treatment groups are indicated (#; p < 0.05). Significant
difference between the ispilateral (treated) and contralateral (control) dentate
gyrus are indicated (∗). HFS + LFT, n = 6; AP5 + HFS + LFT, n = 4; LFT
alone, n = 5; AP5 + LFT, n = 5. (D) Fold change in miRNA expression in
dentate gyrus Ago2 immunoprecipitates at 30min post-HFS. Significant
differences between the HFS group and other treatment groups are
(Continued)
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FIGURE 3 | Continued
indicated (#; p < 0.05). Significant difference between the ispilateral (treated)
and contralateral (control) dentate gyrus are indicated (∗). (E) Relative fold
change in miRNA expression in dentate gyrus Ago2 immunoprecipitates
compared to dentate gyrus lysates (Ago2/input expression ratios) at 30min
post-HFS. Bar graph shows relative fold change in treated dentate gyrus
relative to control, contralateral dentate gyrus. Significant differences
between the HFS group and other treatment groups are indicated (#;
p < 0.05). Significant difference between the ispilateral (treated) and
contralateral (control) dentate gyrus are indicated (∗).
As a functional validation of LTP-specific gene expression
in the dentate gyrus, qPCR analysis of Arc mRNA was per-
formed. Arc is an immediate early gene of importance for pro-
tein synthesis-dependent synaptic plasticity and memory storage
(Bramham et al., 2010). NMDAR-dependent Arc expression is
tightly linked to LTP induction in the dentate gyrus (Messaoudi
et al., 2007; Panja et al., 2009). Arc mRNA expression was ele-
vated 34-fold in the HFS + LFT treated dentate gyrus relative
to contralateral dentate gyrus and this increase was blocked
by AP5-infusion and was absent in groups receiving LFT only
(Figure 3B).
Eleven miRNAs from the high-throughput screen were cho-
sen for qPCR validation. These selected miRNAs included the
seven most strongly upregulated miRNAs (miR-330, miR-338,
miR-223, miR-20a, miR-181a, miR-592, miR-212) in the Ago2 IP
at 30min, the only downregulated miRNA (miR-29b) in the Ago2
IP at 30min, and the three most strongly upregulated miRNAs
(miR-219, miR-384, let-7f) in the Ago2 IP at 120min post-HFS
(significant by t-test with Dunn–Bonferroni correction and 1-
Way ANOVAwith LSD test). For normalization of the qPCR data,
miR-345-3p was used as the most stably expressed miRNA across
samples. miR-181a levels were detected in the HFS-treated den-
tate gyrus but were below the detection limit in the contralateral
(unstimulated) dentate gyrus. miR-181a was therefore excluded
from quantitative analysis.
The results of the qPCR analysis of the 10 miRNAs examined
are shown in Figures 3C–E. The Ct values obtained in treated
dentate gyrus were normalized to control Ct values in the con-
tralateral dentate gyrus for each rat. This was done separately for
the input (Figure 3C) and Ago2 IP (Figure 3D) samples. Eight of
the 10 miRNAs with altered expression in the Ago2 IP on the PCR
card were similarly regulated by qPCR (Table A1). Overall, larger
increases were obtained by TaqMan qPCR, which may reflect a
wider dynamic range of Ct values obtained by cDNA amplifi-
cation in the TaqMan analysis. Robust quantitative differences
in miRNA expression were observed between input samples and
Ago2 IP samples. Five miRNAs (miR-384, miR-29b, miR-219,
miR-592, and miR-20a) exhibited 2 to 5-fold greater increases
in expression in the Ago2 immunoprecipitate than in the input
samples, relative to contralateral control values (Figures 3C,D).
miR-330 and miR-223 expression was unchanged or slightly
decreased in input samples at 30min post-HFS but enhanced in
the Ago2 IP. In contrast, miR-let7f and miR-338 exhibited 2-fold
greater increases in the input sample compared to the Ago2 pel-
let. Finally, miR-212 was elevated in the input sample, but was
significantly decreased in abundance in the Ago2 pellet.
Next we examined the role of NMDA receptor activation in
regulation of miRNA expression. Local infusion of AP5 blocked
LTP induction and prevented the increase in miRNA expres-
sion in input samples and Ago2 IP samples. Remarkably, all 10
miRNAs, including those that were not regulated or decreased
in the HFS group, exhibited a significant decrease in expression
when HFS was applied in the presence of AP5. No significant
changes in miRNA expression were observed in Ago2 IP or
input samples of the LFT or LFT + AP5 treatment groups. An
analysis of the Ago2/input ratios revealed two distinct patterns
of miRNA expression (Figure 3E). Seven miRNAs (miR-384,
miR-29b, miR-219, miR-592, miR-20a, miR-330, and miR-223)
showed enhanced, NMDAR-dependent association with Ago2. In
contrast, 3 miRNAs (miR-let7f, miR-338, and miR-212) exhibited
decreased expression in the Ago2 IP relative to input.
REGULATION OF Arc-TARGETING miRNAs
Recently, Wibrand et al. (2012) identified a set of miRNAs which
bind to the Arc 3′ UTR and inhibit Arc protein expression in
HEK293 cells and primary hippocampal neuronal cultures. Given
the central role of Arc mRNA expression and translation in den-
tate gyrus LTP (Messaoudi et al., 2007; Panja et al., 2009), we
were interested in determining the Ago2/IP expression pattern of
Arc-targeting miRNAs. In input samples, all three miRNAs exam-
ined (miR-34a, miR-19a, miR-326) showed enhanced expression
30min post-HFS and decreased expression below the contralat-
eral control level when HFS was given in the presence of AP5
(Figure 4A). Analysis of the Ago2 IP and Ago2 IP/input expres-
sion ratios revealed enhanced NMDAR-dependent association of
miR-34a with Ago2 make this (Figures 4B,C). In contrast, miR-
19a showed no change and miR-326 had a significantly decreased
Ago2/IP expression ratio following HFS. When AP5 was infused
prior to HFS, the Ago2/IP expression ratio of miR-19a and miR-
326 was increased, indicating NMDAR-dependent dissociation of
these miRNA from Ago2 (Figure 4C).
STABLE EXPRESSION OF ARGONAUTE 2 PROTEIN DURING LTP
Levels of Argonaute protein are known to influence the stability
of miRNA (Winter and Diederichs, 2011).We therefore examined
the expression of Argonaute protein as a potential mechanism for
the differential regulation of total and Ago2-immunoprecipitated
miRNAs. As shown in Figure 5, immunoblot analysis showed no
change in Ago2 expression in input and Ago2-immunoprecipated
samples at 30 and 120min post-HFS (Figure 5).
miRNA TARGET GENE PREDICTION AND PATHWAY ANALYSIS
In order to better understand the potential downstream effects
of the activity-dependent enhanced and depleted Ago2-associated
miRNAs we integrated predictions from four of the most
commonly used miRNA target prediction resources; DIANA
(Maragkakis et al., 2011), miRanda (Griffiths-Jones et al., 2008),
TargetScan (Friedman et al., 2009), and PicTar (Lall et al., 2006)
using the RP method (Breitling et al., 2004). This allowed us
to mitigate for the poor agreement normally found between
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FIGURE 4 | Regulation of Arc-targeting miRNAs in LTP. Quantitative PCR
was used to examine the expression of a set of 3 Arc-associated miRNAs
at 30min. The same set of miRNAs were analyzed in the input sample (A)
and Ago2 immunoprecipitate (B). The qPCR data was normalized to the
expression of miR-345-3p. (A) Fold change in Arc-associated miRNA
expression in dentate gyrus lysates at 30min post-HFS. Bar graph shows
mean fold change (+s.e.m.) in treated dentate gyrus relative to control,
contralateral dentate gyrus. HFS + LFT, n = 6; AP5 + HFS + LFT, n = 4; LFT
alone, n = 5; AP5 + LFT, n = 5. Significant differences between the HFS
group and other treatment groups are indicated (#; p < 0.05). Significant
difference between the ispilateral (treated) and contralateral (control)
dentate gyrus are indicated (∗). (B) Fold change in Arc-associated miRNA
expression in dentate gyrus Ago2 immunoprecipitates at 30min post-HFS.
Significant differences between the HFS group and other treatment groups
are indicated (#; p < 0.05). Significant difference between the ispilateral
(treated) and contralateral (control) dentate gyrus are indicated (∗). (C)
Relative fold change in Arc-associated miRNA expression in dentate gyrus
Ago2 immunoprecipitates compared to dentate gyrus lysates (Ago2/input
(Continued)
FIGURE 4 | Continued
expression ratios) at 30min post-HFS. Significant differences between the
HFS group and other treatment groups are indicated (#; p < 0.05).
Significant difference between the ispilateral (treated) and contralateral
(control) dentate gyrus are indicated (∗).
FIGURE 5 | Stable expression of Argonaute 2 protein during LTP. (A)
Immunoprecipitation of Ago2 30 and 120min post-HFS. Representative
immunoblot of Ago2 expression levels in input, Ago2 immunoprecipitate
(Ago2 IP), and unbound fraction. (B) Bar graph shows mean % change
(+s.e.m.) in Ago2 levels in input and Ago2-IP samples of treated dentate
gyrus relative to the contralateral citation(untreated) dentate gyrus (n = 17).
different target gene prediction algorithms (Reyes-Herrera and
Ficarra, 2012). Target gene list sizes for miRNAs with activity-
dependent association with Ago2 for the 8 enhanced miRNAs
were 97 (miR-20a), 156 (miR-219), 58 (miR-223), 114 (miR-29b),
30 (miR-330), 91 (miR-34a), 156 (miR-384), and 53 (miR-592)
and for the 5 depleted miRNAs were 52 (let-7f), 55 (miR-338), 47
(miR-212), 255 (miR-19a), 32 (miR-326).
We next created three union target gene sets of 684 (enhanced),
418 (depleted), and 1019 (combined) predicted miRNA target
genes to use as input for pathway enrichment analysis using the
Bioconductor KEGGprofile package (Zhao, 2012). The combined
list miRNA targets are strongly enriched in a number of key bio-
logical pathways relevant to activity-dependent synaptic plasticity
(Table 1) including MAPK, mTOR, and Ras signaling pathways.
Of particular note is the greater than 4-fold over-
representation (p = 4.73 × 10−11) of genes traditionally
involved in the mediation of axon guidance. Figure 6 shows a
schematic of the axon navigation pathway annotated to show
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Table 1 | KEGG pathways targeted by the 13 activity-dependent
miRNAs.
KEGG Pathway N FC p
4360 Axon guidance 25 4.32 4.72E-11
4510 Focal adhesion 30 3.23 1.37E-09
4151 PI3K-Akt signaling pathway 35 2.28 5.02E-07
4320 Dorso-ventral axis formation 7 7.15 2.58E-06
4014 Ras signaling pathway 24 2.29 2.68E-05
4010 MAPK signaling pathway 25 2.15 5.46E-05
4150 mTOR signaling pathway 10 3.51 9.65E-05
4070 Phosphatidylinositol signaling system 11 3.01 2.27E-04
4350 TGF-beta signaling pathway 10 2.74 8.76E-04
4720 Long-term potentiation 8 2.77 2.06E-03
4144 Endocytosis 19 1.82 2.87E-03
4725 Cholinergic synapse 11 2.19 3.86E-03
4810 Regulation of actin cytoskeleton 17 1.74 6.99E-03
4722 Neurotrophin signaling pathway 11 2.01 7.52E-03
562 Inositol phosphate metabolism 7 2.35 8.92E-03
3018 RNA degradation 8 2.22 8.97E-03
4310 Wnt signaling pathway 12 1.90 9.12E-03
4120 Ubiquitin mediated proteolysis 11 1.82 1.58E-02
4340 Hedgehog signaling pathway 5 2.34 1.84E-02
3060 Protein export 3 2.81 2.00E-02
4728 Dopaminergic synapse 10 1.72 2.83E-02
KEGG, KEGG accession number; N, number of target genes in pathway; FC, fold
enrichment over expected.
the targeting of enhanced and depleted miRNAs. The enhanced
miRNA pool remarkably targets receptors of all four signaling
families of the pathway; ephrins, netrins, semaphorins, and Slits
as well as MAPK1 and GSK3β which have well-established roles
in the regulation of activity-dependent synaptic plasticity. Both
enhanced and depleted microRNAs appear to heavily target genes
involved in ephrin signal transduction especially the cascade
directly upstream of MAPK1. The only place where enhanced
and depleted targets directly oppose each other is in differential
targeting of the Robo1 and Robo2 receptors for Slit1/2.
Pathway enrichment analyses with the individual enhanced
and depleted lists produce very similar pathway enrichment pro-
files to the combined lists (see Tables A2, A3).
DISCUSSION
microRNA levels are dictated by a multistep biogenesis path-
way and probably multiple mechanisms for miRNA decay (Kai
and Pasquinelli, 2010; Meister, 2013). Knowledge of miRNA
expression during synaptic plasticity has so far relied on mea-
surements in lysates from whole tissue or subcellular fractions. In
the canonical biogenesis pathway, the guide strand of the mature
miRNAs is bound by Ago to form the miRISC. Mature miRNA
is considered to be present predominantly in tight complex with
Argonaute. The present analysis of LTP in the dentate gyrus of
anesthetized rats demonstrates differential regulation of mature
miRNA expression in whole lysates and the Ago2 immunopre-
cipitated fraction. Both quantitatively and qualitatively, miRNA
expression in tissue lysates does not accurately reflect changes in
the miRNA content of the Ago2-RISC. The ratio of Ago2/total
miRNA expression was regulated bidirectionally in a miRNA-
specific manner and was largely dependent on NMDA receptor
activation during LTP induction. The present results identify
miRNA association with Ago2 as a potential control point in
activity-dependent synaptic plasticity in the adult brain.
The high-throughput screen comparing HFS-treated and con-
tralateral dentate gyrus indicated dynamic and differential regu-
lation of total and Ago2-immunoprecipated miRNAs. A systemic
validation using TaqMan qPCR demonstrated differential regula-
tion at 30min post-HFS. When comparing miRNA Ago2/input
expression ratios, eight miRNAs (miR-384, miR-29b, miR-219,
miR-592, miR-20a, miR-330 miR-223, and miR-34a) exhibited
increases relative to the contralateral dentate gyrus, whereas five
miRNAs (miR-let7f, miR-338, miR-212, miR-19a, and miR-326)
showed decreases in this ratio. The results demonstrate activity-
dependent, miRNA-specific regulation of miRNA abundance in
the Ago2-RISC relative to total miRNA. The enhanced expres-
sion of miRNA and enhanced associated with Ago2 was specific
to NMDA receptor-dependent LTP induction, as was the decrease
in the Ago2/input ratio for miR-let7f andmiR-326. These changes
in miRNA expression were blocked when HFS was applied in the
presence of NMDAR antagonist, AP5, and were absent when low-
frequency test stimulation was applied alone or in combination
with AP5 infusion. We therefore conclude that LTP induction
is coupled to NMDAR-dependent regulation of miRNA expres-
sion and miRNA-specific interactions with Ago2. In addition,
those miRNAs upregulated following HFS exhibited significant
downregulation upon LTP block by AP5, which was not seen in
the low-frequency test stimulation control groups. This indicates
that HFS also acts through an unknown, NMDAR-independent
mechanism to downregulate miRNA expression and its associa-
tion with Ago2. Finally, this work does not exclude the possibility
of small changes inmiRNA expression in the contralateral dentate
gyrus, although we have demonstrated LTP-specific regulation of
miRNAs in the HFS-treated dentate gyrus.
Consistent with our previous work (Wibrand et al., 2010),
expression of miR-212 and miR-132 was increased in dentate
gyrus lysates at 120min post-HFS. Wibrand and colleagues
observed NMDAR-dependent decreases in mature miR-212 and
miR-132 in the absence of NMDAR-dependent effects on precur-
sor miRNA levels, suggesting that NMDAR signaling promotes
decay of the mature miRNAs. Consistent with increased turnover,
decreased expression was observed for ∼50% of the miRNAs that
were regulated in the input samples at 30 and 120min post-
HFS. However, the present work focused on qPCR validation of
miRNAs that were upregulated in the Ago2 IP.
Park and Tang (2009) used miRNA arrays to determine the
temporal expression profiles of 62 miRNAs in adult mouse hip-
pocampal slices following induction of chemical LTP (C-LTP)
and metabotropic glutamate receptor-dependent LTD (mGluR-
LTD). The study demonstrated regulation of total (lysate) miRNA
expression for the majority of miRNAs (50/61) by both C-LTP
and mGluR-LTD. Most regulated miRNAs exhibited rapid upreg-
ulation at 15min and declined thereafter but were still upregu-
lated 2 h after LTP or LTD induction. In the present in vivo study,
LTP was induced by patterned HFS of the medial perforant path
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FIGURE 6 | Axon navigation pathway targeting by miRNAs that
differentially associate with Ago2 in an activity-dependent manner.
Genes targeted by miRNAs that differentially associate with Ago2 in an
activity-dependent manner are color coded by whether they are targeted
by enhanced (green box), depleted (red box), or by both enhanced and
depleted miRNAs (brown box). The involvement of all four guidance
molecule families and their convergence on signal transduction systems
classically associated with activity-dependent synaptic plasticity suggests
an important role for these receptor mediated signaling pathways in
plasticity.
input to the dentate gyrus. Rapid regulation at 30min post-HFS
was also observed in the present study, particularly in the Ago2
IP samples. However, the high-throughput screen shows delayed
(2 h) bidirectional changes in miRNA expression in both Ago2
immunoprecipitates and lysates.
REGULATON OF Ago2-microRNA INTERACTIONS
The differential regulation of Ago2 immunoprecipitated and total
miRNA expression indicates the existence of a substantial non-
Ago2-bound or “free” miRNA fraction. A key issue to be resolved
is the nature of the non-Ago2-bound pool. This pool may con-
sist of (1) mature miRNAs in the RISC loading complex ready
to be loaded onto Ago, (2) miRNAs discharged from Ago follow-
ing degradation of the target mRNA, (3) miRNAs weakly bound
to Ago2 which dissociate during sample preparation, and (4)
miRNAs bound to other members of the Argonaute family.
Co-expression of Argonaute family proteins (Ago1, 2, 3, and 4)
occurs in many animal cell types including neurons. The four Ago
proteins appear to play overlapping roles in mammals (Juvvuna
et al., 2012; Meister, 2013). All mammalian Ago proteins contain
PAZ, MID, and PIWI domains. The PAZ domain anchors the
3′-end of the miRNA, while the MID domain harbors a bind-
ing pocket for the 5′-end of the miRNA. The PIWI domain of
Ago2, but not of other mammalian Ago proteins, has endonucle-
olytic activity capable of cleaving perfectly complementary sites.
In mammals, however, miRNAs bind predominantly to partially
complementary mRNA and Ago2-mediated “slicing” of target
mRNA is uncommon. Rather, the mammalian Ago-RISC inhibits
translation and promotes deadenylation-induced mRNA decay.
Recent work suggests a sequential mechanism whereby rapid
translation inhibition is followed by slow mRNA degradation
(Béthune et al., 2012; Djuranovic et al., 2012).
Mammalian miRNAs are thought to be randomly sorted onto
the four Argonaute proteins rather than targeted to specific Ago
proteins (Dueck et al., 2012; Wang et al., 2012). If this is true
for the brain, then analysis of Ago2 immunoprecipitated miRNAs
can be considered representative of miRNA regulation as a whole.
Wang et al. (2012) immunoprecipitated Ago1–3 from mouse
keratinocytes and human melanoma cells and performed qPCR
analysis to quantify the levels of miRNAs that interact with each
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Ago species. Ago2 interacted with a majority of miRNAs (60%),
compared with Ago1 (30%) and Ago3 (<10%) in a proportion
that matched the abundance of each Ago. However, processing of
some miRNA precursors is mediated by Ago2 rather than Dicer.
Dueck et al. (2012) demonstrated that ectopically expressed miR-
451 in HEK293 cells is not only processed by Ago2 but also
loaded exclusively onto Ago2-associated RISC. Once associated
with Ago2, the mature miRNA is not exchanged with other Ago
family proteins. In medium spiny neurons of the striatum, Ago2
(but not other Agos) contributes to the expression of some 25%
of mature miRNAs (Schaefer et al., 2010). Therefore, it is pos-
sible that the Ago2 immunoprecipitated miRNAs identified in
the present study are skewed toward Ago2 processing-dependent
miRNAs. Immunoprecipitation of other Ago family proteins is
needed to address the issue.
Recent work suggests that miRNA loading onto Ago is a reg-
ulated process. The minimal RISC loading complex consists of
Dicer, the double-stranded RNA-binding protein, TRBP, heat-
shock protein 90, and Ago. The current view is that miRNA
loading onto Ago occurs in two-steps (Meister, 2013). Themature
microRNA duplex is first bound by TRBP, which repositions the
duplex on Dicer in an orientation that affords correct strand
selection. The actual transfer of the miRNA duplex to Ago is
mediated by heat shock protein 90 (HSP90), which binds Ago
and keeps it in an open state capable of capturing the miRNA.
Additional mechanisms likely exist for sequestering miRNA from
Ago. For example, the RNA-binding protein, hnRNP E2, has been
shown to reversibly sequester miR-328 away from Ago, Dicer, and
other proteins of the RISC loading complex (Eiring et al., 2010).
A set of positive-charged arginine amino acids concentrated in
the nucleotide-binding channel in Ago stabilizes the interaction
of the protein with miRNA (Wang et al., 2010). However, molec-
ular dynamic simulations and thermodynamic analysis indicate
that conformational changes within the flexible PAZ domain
could affect the recognition and release of miRNA (Wang et al.,
2010). Recent evidence suggests that Ago2 is also extensively reg-
ulated by phosphorylation. A highly conserved tyrosine (Y529)
located in the 5′-end-binding pocket of Ago2’s MID domain
can be phosphorylated (Rüdel et al., 2011). This phosphory-
lation inhibits small RNA binding to Ago2, suggesting that it
may serve as a reversible molecular switch on miRNA bind-
ing. If Ago2 conformation is so regulated during LTP, this could
provide a basis for the reversible modulation of Ago2:miRNA
binding.
By stabilizing guide-stranded mature miRNA, Ago vastly
extends the half-life of miRNA. Downregulation or ectopic
expression of Ago results in decreased or enhanced miRNA lev-
els, respectively (Winter and Diederichs, 2011). Hence, changes
in Ago2 abundance would be expected to influence miRNA lev-
els. However, modulation of Ago2 levels does not appear to be
a contributing mechanism in LTP, as there was no change in the
amount of total or immunoprecipitated Ago2 at 30 or 120min
after LTP induction.
Work in C. elegans suggests that target mRNA availabil-
ity is a key factor in determining the release of miRNA from
Argonaute and subsequent degradation of themiRNA (Chatterjee
and Grosshans, 2009). miRNA binding to target stabilizes the
miRNA:Ago interaction. miRNAs bound to abundant and sta-
ble mRNA will themselves be stable. Upon degradation of the
target mRNA, miRNAs are released from Ago and degraded.
Accordingly, changes in the mRNA expression profile during LTP
are likely to influence the ratio of Ago2-bound to free miRNA in
an miRNA-specific manner.
Circular RNAs (circRNAs) are a major class of regulatory
RNAs which function to sponge endogenous miRNAs (Hansen
et al., 2013; Memczak et al., 2013). CircRNAs are diverse (at least
2000 in human and mouse), abundantly expressed in brain, and
contain numerous miRNA binding sites. miR-7 binding to a spe-
cific circRNA (csRS-7) results in robust derepression of miR-7
mRNA targets in neurons. Although miRNAs remain bound to
Ago on circRNAs, circRNAs are resistant to miRISC-mediated
destabilization. As a result, any movement or exchange of miR-
NAs between their binding sites on circRNA and mRNA is likely
to shift the balance between free and Ago2-associated miRNA.
Regulation of circRNAs in LTP is hypothetical at present, but
could potentially contribute to rapid changes in the Ago2-miRNA
pool.
A recent study in cortical synaptosomes suggests that axon ter-
minals accumulate, store, and secrete miRNAs (Xu et al., 2013).
Synaptosomes are biochemical fractions containing axon ter-
minals that are pinched-off and released, often together with
components of the postsynaptic membrane. The authors charac-
terized miRNA profiles in synaptosomes using microarrays and
qPCR. Endogenous Ago2-bound miRNAs were enriched in the
synaptic vesicle fraction. Synthetic miR-125 was also taken up by
the synaptosomes through a non-specific endocytic mechanism.
Interestingly, the proportion of Ago2/total miRNAs in the synap-
tosome varied considerably among the 21 miRNAs, indicating
that a miRNA-specific, non-Ago2-bound pool exists. Upon KCL-
evoked depolarization, endogenous miRNAs are secreted from
synaptosomes still attached to Ago2. It is therefore possible that
secretion of Ago2 bound miRNAs, from postsynaptic or presy-
naptic compartments, alters the equilibrium between free and
Ago2-bound miRNAs.
miRNA TARGET PREDICTION AND PATHWAY ANALYSIS
Central to our understanding of miRNA function is the iden-
tification of their direct molecular targets. To date, no direct
binding screens have taken place in experimental systems relevant
to activity-dependent synaptic plasticity although techniques now
exist to do so (Helwak et al., 2013). In the absence of such data we
rely on miRNA target prediction algorithms that use structural,
sequence and evolutionary based features of known miRNA-
binding sites (Reyes-Herrera and Ficarra, 2012). Despite their
widespread adoption, however, there is poor agreement between
predictions made by different algorithms for the same miRNA.
We adopted the RP approach to identify the most consistently
predicted target genes from four of the most widely used miRNA
target prediction algorithms. This produced mutually supportive
target gene lists of on average 100 genes per miRNA that had lost
94.9% of predicted targets during the cross-comparison analysis
by RP (Table A4).
Comparison of the biological pathways targeted by miRNAs
with enhanced and depleted activity-dependent Ago2 association
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revealed 21 significantly enriched pathways (p ≤ 0.05). Among
these were many previously reported to play roles in the reg-
ulation of activity-dependent synaptic plasticity in four broad
categories including remodeling and turnover pathways: cell-cell
adhesion (Gerrow and El-Husseini, 2006), actin cytoskeletal rear-
rangement (Bosch and Hayashi, 2012), endocytosis (Huganir and
Nicoll, 2013; Jiang and Ehlers, 2013) proteolysis and protein
export (Bingol and Sheng, 2011), signal transduction pathways:
ERK/MAPK (English and Sweatt, 1997; Rosenblum et al., 2002;
Ying et al., 2002; Kelleher et al., 2004), PI3K-Akt, mTOR (Hoeffer
and Klann, 2010), Ras (Stornetta and Zhu, 2011), TGFβ, neu-
rotrophin, and Wnt (Poon et al., 2013), process pathways: LTP,
cholinergic and dopaminergic synapse activity and developmen-
tal pathways: axon guidance and dorso-ventral axis formation.
This latter group show the highest and most significant enrich-
ment in our miRNA targets and emerging evidence supports a
central role for classical developmental pathways such as axon
guidance in the regulation of synaptic plasticity (Wibrand et al.,
2006; Knafo and Esteban, 2012). Indeed the intracellular signaling
pathways through which netrins (Bayat et al., 2012; Horn et al.,
2013), ephrins (Lim et al., 2008; Klein, 2009), Slits (Soderling
et al., 2007), and semaphorins (Pasterkamp and Giger, 2009)
operate are the same pathways found to be functional during
activity-dependent synaptic plasticity.
CLOSING COMMENTS
In sum, the present work provides evidence for bidirectional
changes in miRNA expression compatible with regulated shut-
tling of miRNA to and from Ago2 in the adult dentate gyrus.
As recent work has succeeded in cell-specific expression profil-
ing of Ago2-associated miRNAs in brain (He et al., 2012), it
will be important to elucidate the signaling pathways and cell
biological mechanisms that dictate time-dependent interactions
of miRNA with Argonautes. In addition, the bioinformatic pre-
dictions for biological processes modulated by Ago2-regulated
miRNAs strongly point to regulation of mechanisms classically
involved in axon guidance.
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APPENDIX
Table A1 | Comparison of PCR card screening to Taqman qPCR
validation results.
miRNA miRNA levels in Ago2 IP
following LTP induction
PCR card qPCR
384 ↑ ↑
29b ↓ ↑
219 ↑ ↑
592 ↑ ↑
20a ↑ ↑
let-7f ↑ ↑
330 ↑ ↑
338 ↑ ↑
223 ↑ ↑
212 ↑ ↓
34a − ↑
19a − ↑
326 − −
Significantly increased expression (↑); significantly decreased expression (↓); no
change (−).
Table A2 | Neural related pathways enriched in targets with
decreased activity-dependent Ago2 association.
KEGG Pathway name N FC P
4360 Axon guidance 19 4.71 1.93E-09
4510 Focal adhesion 24 3.70 3.23E-09
4151 PI3K-Akt signaling pathway 28 2.62 3.46E-07
4512 ECM-receptor interaction 11 4.07 1.23E-05
4150 mTOR signaling pathway 8 4.03 1.35E-04
4070 Phosphatidylinositol signaling system 9 3.54 1.91E-04
4010 MAPK signaling pathway 18 2.22 3.11E-04
4320 Dorso-ventral axis formation 4 5.86 4.66E-04
4014 Ras signaling pathway 16 2.19 7.16E-04
562 Inositol phosphate metabolism 7 3.37 9.74E-04
4728 Dopaminergic synapse 10 2.46 2.15E-03
3018 RNA degradation 7 2.78 3.29E-03
4350 TGF-beta signaling pathway 7 2.75 3.55E-03
4310 Wnt signaling pathway 9 2.04 1.14E-02
4720 Long-term potentiation 5 2.48 1.45E-02
5031 Amphetamine addiction 5 2.48 1.45E-02
4810 Regulation of actin cytoskeleton 12 1.76 1.57E-02
4330 Notch signaling pathway 4 2.53 1.98E-02
5034 Alcoholism 10 1.77 2.25E-02
4722 Neurotrophin signaling pathway 7 1.83 3.44E-02
4730 Long-term depression 4 2.08 4.15E-02
Table A3 | Neural related pathways enriched in targets with increased
activity-dependent Ago2 association.
KEGG Pathway name N FC P
4360 Axon guidance 13 6.01 2.13E-08
4320 Dorso-ventral axis formation 5 13.66 1.11E-06
4010 MAPK signaling pathway 14 3.22 1.77E-05
4540 Gap junction 7 4.73 9.98E-05
4014 Ras signaling pathway 12 3.07 1.01E-04
4725 Cholinergic synapse 7 3.72 5.10E-04
4720 Long-term potentiation 5 4.62 6.69E-04
4120 Ubiquitin mediated proteolysis 7 3.09 1.68E-03
4350 TGF-beta signaling pathway 5 3.66 2.23E-03
4722 Neurotrophin signaling pathway 6 2.93 3.96E-03
4530 Tight junction 6 2.61 7.31E-03
4730 Long-term depression 3 2.91 1.89E-02
4721 Synaptic vesicle cycle 3 2.86 1.99E-02
4510 Focal adhesion 7 2.01 2.00E-02
4150 mTOR signaling pathway 3 2.82 2.10E-02
4810 Regulation of actin cytoskeleton 7 1.91 2.60E-02
4310 Wnt signaling pathway 5 2.12 2.86E-02
4668 TNF signaling pathway 4 2.23 3.21E-02
4020 Calcium signaling pathway 6 1.91 3.40E-02
4340 Hedgehog signaling pathway 2 2.50 4.46E-02
4151 PI3K-Akt signaling pathway 9 1.57 4.82E-02
5034 Alcoholism 5 1.65 7.58E-02
Table A4 | Reduction in target gene list size resulting from rank
product analysis.
miRNA UTn RPn
let-7f 2195 52
miR-19a 1806 255
miR-20a 2244 97
miR-212 1365 47
miR-219 2205 156
miR-223 1274 58
miR-29b 2684 114
miR-326 1455 32
miR-330 2005 30
miR-338 2055 55
miR-34a 1588 91
miR-384 2064 156
miR-592 437 53
Total 23377 1196 (5.1%)
UTn, Unique targets; RPn, Rank products.
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